|
Quotes & Info
|
| PSDV > SEC Filings for PSDV > Form 8-K on 22-Mar-2013 | All Recent SEC Filings |
22-Mar-2013
Other Events, Financial Statements and Exhibits
On March 22, 2013, pSivida Corp. issued a press release announcing updates from Alimera Sciences, Inc. related to ILUVIEN®for diabetic macular edema, including the timing of Alimera's expected resubmission of a New Drug Application for ILUVIEN® to the U.S. Food and Drug Administration (FDA), the timing of Alimera's expected commencement of shipments of ILUVIEN® in Germany and the submission of a patient access scheme for ILUVIEN ®. pSivida's press release is filed as Exhibit 99.1 to this Current Report on Form 8-K.
No. Description
99.1 Press release of pSivida Corp. dated March 22, 2013
|
|